Prevalence, Risk Factors, Prognosis, and Management of Pericardial Effusion in COVID-19
Prevalence, Risk Factors, Prognosis, and Management of Pericardial Effusion in COVID-19
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Background: There is limited data in the literature about the clinical importance and prognosis of pericardial effusion (PE) in patients discharged after recovering from COVID-19, but large-scale studies have yet to be available. This study investigated the prevalence, risk factors, prognosis, late clinical outcomes, and management of PE in COVID-1...
Alternative Titles
Full title
Prevalence, Risk Factors, Prognosis, and Management of Pericardial Effusion in COVID-19
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6da631c8a41e4696a48c1be3d81b14f5
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6da631c8a41e4696a48c1be3d81b14f5
Other Identifiers
ISSN
2308-3425
E-ISSN
2308-3425
DOI
10.3390/jcdd10090368
